✦ LIBER ✦

In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939—an oral, direct Factor Xa inhibitor

✍ Scribed by E. PERZBORN; J. STRASSBURGER; A. WILMEN; J. POHLMANN; S. ROEHRIG; K-H. SCHLEMMER; A. STRAUB

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Apixaban, an oral, direct and highly sel

✍ P. C. WONG; E. J. CRAIN; B. XIN; R. R. WEXLER; P. Y. S. LAM; D. J. PINTO; J. M. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 371 KB

Safety, pharmacodynamics, and pharmacoki

✍ Dagmar Kubitza; Michael Becka; Georg Wensing; Barbara Voith; Michael Zuehlsdorf 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 768 KB

BAY 59-7939: an oral, direct Factor Xa i

✍ A. G. G. TURPIE; W. D. FISHER; K. A. BAUER; L. M. KWONG; M. W. IRWIN; P. KÄLEBO; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB